Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |